Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
Conditions: Liver Transplant; Complications; Hepatocarcinoma; Recurrent Osteosarcoma; High-Risk Cancer Intervention: Drug: multi-kinase inhibitors in combination with bevacizumab Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
Condition: Liver Transplant Intervention: Behavioral: Prehabilitation Sponsors: Belfast Health and Social Care Trust; Queen's University, Belfast Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials